bacteri
strain
growth
condit
agalactia
capsular
type
iii
cerebrospin
fluid
csf
strain
belong
hypervirul
lineag
isol
brazil
male
babi
fatal
acut
mening
use
studi
microorgan
identifi
group
b
streptococci
type
method
previous
describ
isol
cultur
blood
agar
base
bab
oxoid
cambridg
uk
plate
contain
sheep
defibrin
blood
h
grown
brain
heart
infus
broth
bhi
difco
laboratori
inc
detroit
mi
usa
optic
densiti
od
nm
cfuml
reach
huvec
cultur
primari
huvec
obtain
treat
umbil
vein
collagenas
iv
solut
sigma
chemic
co
st
loui
mo
usa
previous
describ
cell
use
first
second
passag
subcultur
obtain
treat
confluent
cultur
edta
solut
phosphatebuff
salin
pb
mm
nacl
mm
phosphat
buffer
ph
sigma
chemic
co
st
loui
mo
usa
bacteri
bind
intracellular
viabil
assay
confluent
cultur
huvec
cell
pretreat
mm
sigma
chemic
co
st
loui
mo
usa
lipid
raft
disruptor
h
inhibitor
sigma
chemic
co
st
loui
mo
usa
min
huvec
allow
interact
agalactia
moi
huvecbacteria
differ
period
incub
h
bacteri
bind
assay
infect
monolay
rins
three
time
lyse
ml
solut
mm
tri
mm
edta
mm
nacl
igep
sigma
chemic
co
st
loui
mo
usa
viabil
total
bacteria
intracellular
plu
surfac
adher
estim
plate
endotheli
lysat
count
result
coloni
emerg
bab
plate
contain
sheep
defibrin
blood
measur
bacteri
internalis
infect
monolay
rins
three
time
medium
incub
addit
h
period
contain
bactericid
amount
gentamicin
sigma
chemic
co
st
loui
mo
usa
penicillin
g
sigma
chemic
co
st
loui
mo
usa
also
perform
count
cell
invad
adher
shortli
interact
agalactia
h
number
internalis
bacteria
determin
outlin
adher
rate
determin
cfu
total
cellassoci
intracellular
viabl
plu
surfac
adher
agalactia
cfu
intracellular
agalactia
untreat
huvec
use
neg
control
experi
repeat
three
time
field
emiss
scan
electron
microscopi
fesem
huvec
monolay
infect
agalactia
h
wash
pb
incub
overnight
solut
paraformaldehyd
plu
glutaraldehyd
made
cacodyl
buffer
strain
wash
postfix
solut
plu
mm
potassium
ferrocyanid
mm
cacodyl
buffer
wash
eight
time
pb
infect
cell
dehydr
grade
seri
ethanol
surfac
infect
monolay
scrape
scotch
tape
order
expos
inner
organis
huvec
cell
dri
critic
point
coat
thin
gold
layer
goldcoat
strain
observ
jeol
field
emiss
scanner
oper
kv
fluoresc
confoc
microscopi
huvec
cell
pretreat
infect
agalactia
h
rins
pb
fix
paraformaldehyd
pb
min
room
temperatur
cell
permeabilis
tritonx
pb
min
incub
primari
antibodi
anti
agalactia
antibodi
clone
h
incub
cell
wash
min
incub
alexa
fluor
alexa
fluor
secondari
antibodi
h
nuclei
label
dapi
cell
mount
prolong
gold
antifad
reagent
examin
use
zeiss
axiovert
laser
confoc
microscop
carl
zeiss
germani
use
filter
set
select
fluorochrom
wavelength
channel
imag
acquir
integr
chargecoupl
devic
camera
hamamatsu
photon
shizuoka
japan
argu
imag
processor
hamamatsu
control
experi
primari
antibodi
show
faint
background
stain
data
shown
reagent
antibodi
obtain
molecular
probe
usa
experi
repeat
three
time
immunoblot
analysi
huvec
monolay
infect
differ
time
agalactia
describ
follow
infect
plate
chill
subsequ
step
carri
huvec
rins
pb
contain
mm
mm
naf
per
ml
next
infect
cell
scrape
plate
ressuspend
ml
buffer
solut
collect
centrifug
min
g
lyse
min
mm
trishcl
ph
contain
mm
mm
naf
triton
phenylethylsulphonylfluorid
leupeptin
mm
edta
protein
quantifi
protein
extract
subject
electrophoresi
polyacrylamid
separ
gel
sdspage
protein
transfer
nitrocellulos
membran
biorad
block
incub
primari
antibodi
membran
incub
second
antibodi
peroxidaseconjug
immunoreact
detect
use
ecl
plu
detect
kit
amersham
bioscienc
buckinghamshir
uk
autoradiograph
quantifi
scan
densitometri
result
absorb
curv
integr
use
scion
imag
master
densitometr
analys
perform
gel
differ
exposur
time
one
give
linear
absorb
curv
use
obtain
semi
quantit
assess
experi
repeat
three
time
statist
analysi
valu
differ
treatment
compar
use
student
ttest
analysi
varianc
anova
follow
bonferroni
test
unpair
valu
statist
analys
perform
p
level
signific
effect
cholesterol
deplet
inhibitor
agalactia
interact
effect
cholesterol
deplet
agent
inhibitor
treatment
agalactia
adher
invas
huvec
display
fig
cholesterol
deplet
affect
bacteri
bind
huvec
h
postinfect
x
cfuml
p
higher
number
adher
bacteria
x
cfuml
p
observ
huvec
pretreat
mainli
h
incub
x
cfuml
p
fig
howev
signific
reduct
agalactia
cytoadhes
observ
huvec
treat
chosen
time
incub
x
cfuml
h
x
cfuml
h
x
cfuml
h
p
fig
agalactia
strain
exhibit
strong
invas
phenotyp
huvec
h
postinfect
moreov
pretreat
huvec
andor
led
decreas
invas
p
fig
fesem
use
demonstr
presenc
intracellular
strain
fig
inhibit
assay
suggest
involv
lipid
raft
pathway
agalactia
internalis
process
human
endotheli
cell
colocalis
agalactia
cellular
localis
agalactia
strain
fig
fig
e
fig
f
huvec
demonstr
immunofluoresc
microscopi
stain
reveal
colocalis
strain
untreat
huvec
cell
fig
colocalis
detect
cell
treat
cholesterol
deplet
agent
fig
also
found
colocalis
strain
pretreat
huvec
fig
untreat
cell
fig
contrast
signific
colocalis
could
observ
strain
huvec
cell
treat
fig
e
result
suggest
could
involv
invas
agalactia
strain
huvec
cell
akt
activ
huvec
cell
agalactia
infect
fig
show
activ
pathway
interact
agalactia
huvec
cell
pretreat
inhibitor
andor
cholesterol
deplet
agent
immunoblot
analysi
reveal
higher
level
phosphoryl
akt
peak
min
postinfect
huvec
agalactia
inhibit
assay
complet
abolish
akt
phosphoryl
fig
verifi
whether
phosphoryl
akt
huvec
cell
treat
independ
follow
infect
strain
specif
inhibitor
incub
prior
bacteri
infect
activ
pathway
occur
min
postinfect
peak
min
inhibitor
reduc
phosphoryl
fig
result
confirm
densitometri
analysi
fig
overal
result
indic
involv
lipid
raft
pathway
activ
agalactia
internalis
human
endotheli
cell
lipid
raft
often
serv
entri
site
mani
microorgan
studi
shown
extract
membran
cholesterol
inhibit
bacteri
infect
earli
stage
invas
mechan
underli
interact
start
unravel
sever
pathogen
bacteria
associ
lipid
raft
francisella
tularensi
helicobact
pylori
pseudomona
gengivali
mycobacterium
tuberculosi
seveau
et
al
demonstr
first
time
cell
adhes
molecul
ecadherin
requir
host
lipid
raft
mediat
listeria
monocytogen
entri
previou
studi
show
agalactia
exploit
lipid
raft
invad
human
endometri
cell
work
evalu
influenc
host
cell
lipid
raft
agalactia
internalis
huvec
use
watersolubl
cyclic
oligosaccharid
deplet
membran
cholesterol
disrupt
lipid
raft
cholesterolenrich
membran
microdomain
may
provid
platform
concentr
receptor
host
cell
membran
data
support
notion
lipid
raft
plasma
membran
huvec
cell
facilit
entri
agalactia
strain
signific
decreas
cytoadhes
strain
human
endotheli
cell
treat
indic
cholesterol
deplet
cell
membran
perturb
attach
bacteria
alter
entri
postbind
step
reduct
number
cholesteroldeplet
cell
probabl
occur
initi
step
infect
sinc
signific
inhibitori
effect
reduc
postinfect
becam
undetect
h
postinfect
data
shown
interact
strain
cholesterolenrich
microdomain
occur
probabl
particip
membran
microdomain
flotillin
present
plasma
membran
endosom
structur
implic
mani
cellular
process
lipid
raft
format
cellular
migrat
adhes
cell
polar
signal
receptor
tyrosin
kinas
mitogen
activ
protein
kinas
mapk
well
membran
traffick
sever
cargo
molecul
gpianchor
protein
cholera
toxin
b
subunit
viru
proteoglycan
proteoglycan
bound
ligand
suggest
utilis
internalis
pathway
depend
flotillin
previou
data
suggest
highli
dynam
flotillin
microdomain
becom
static
prior
internalis
might
caus
coalesc
flotillin
oligom
larger
oligomer
structur
particip
format
specif
noncaveolar
microdomain
current
result
suggest
agalactia
induc
assembl
specif
flotillin
microdomain
induc
membran
curvatur
thu
gener
membran
bud
entri
huvec
interestingli
enrich
postlamp
endocyt
organel
matur
phagosom
might
involv
actin
filament
remodel
lipid
chang
phagosomelysosom
fusion
studi
verifi
colocalis
agalactia
earli
endosom
progress
interestingli
treatment
decreas
colocalis
strain
favor
bacteri
interact
cholesterol
level
import
maintain
membran
fluiditi
remov
reduc
later
diffus
within
cell
membran
reduct
fluiditi
could
perhap
affect
distribut
receptor
within
plasma
membran
may
damag
signal
transduct
event
polaris
factin
polymeris
result
suggest
cholesterol
deplet
may
expos
molecul
favor
recognit
strain
critic
enhanc
innat
immun
respons
contribut
surviv
lpsinduc
sepsi
also
observ
intracellular
parasit
inhibit
lysosom
fusion
classic
escap
mechan
observ
infect
mycobacterium
chlamydia
toxoplasma
trypanosoma
cruzi
exampl
anoth
way
pathogen
prolong
surviv
insid
host
prevent
hostcel
apoptosi
modul
reactiv
oxygen
nitrogen
speci
gener
szczepanski
et
al
reveal
canin
respiratori
coronaviru
enter
cell
via
depend
pathway
thu
previou
result
support
notion
might
play
role
interact
agalactia
huvec
cell
serinethreonin
kinas
akt
activ
g
proteincoupl
receptor
induc
product
phosphatidylinositol
trisphosph
work
demonstr
integr
lipid
raft
microdomain
activ
requir
invas
strain
human
endotheli
cell
inde
phosphoryl
akt
suppress
cholesterol
deplet
use
suggest
membran
microdomain
integr
import
activ
agalactia
infect
pere
et
al
show
membran
microdomain
essenti
site
activ
lysophosphatid
acid
stimul
vero
cell
lipid
raft
also
induc
platelet
aggreg
via
akt
phosphoryl
stromal
cellderiv
signal
exclud
possibl
result
obtain
studi
could
specif
agalactia
type
iii
belong
hypervirul
capsular
type
iii
strain
could
behav
differ
way
studi
necessari
unravel
possibl
result
demonstr
lipid
microdomain
affect
agalactia
recognit
huvec
signal
pathway
addit
agalactia
cytoadhes
use
membran
microdomain
suggest
select
role
lipid
raft
molecul
henc
understand
role
host
membran
raft
agalactia
invas
may
shed
light
molecular
mechan
infect
